Jaundice & Kernicterus in Rhode Island

When Newborn Jaundice Progresses to Permanent Neurologic Injury

Jaundice is very common in newborns. Kernicterus is not.

Jaundice develops when bilirubin accumulates in a baby's blood faster than the body can eliminate it. Most newborn jaundice does not result in lasting harm. But when bilirubin rises to dangerous levels and the infant does not receive appropriate monitoring and treatment, bilirubin toxicity can injure the brain.

Severe bilirubin toxicity can first cause acute bilirubin encephalopathy, which describes neurologic symptoms appearing during the newborn period. Kernicterus refers to the chronic and permanent neurologic injury that can remain after bilirubin damages the brain.

At Decof, Mega & Quinn, P.C., we have represented injured people and families since 1975. Our Rhode Island birth injury practice includes complex cases in which medical records and expert review are necessary to determine whether failures in newborn monitoring, treatment, or follow-up contributed to preventable harm.ired at every step and where it may have broken down.

If your newborn developed jaundice-related brain damage and you believe the hospital fell short, call our Rhode Island birth injury attorneys today at (401) 200-4059 for a free consultation. You can also contact us online.

The Critical Window for Detecting Severe Hyperbilirubinemia

Visible jaundice can be an important sign, but appearance alone cannot reliably tell clinicians how high a newborn's bilirubin level is.

Current American Academy of Pediatrics guidance for infants born at 35 weeks gestation or later recommends measuring either transcutaneous bilirubin or total serum bilirubin between 24 and 48 hours after birth, or before discharge if the infant leaves earlier.

That measurement is only one part of the process.

The bilirubin level must be interpreted in context, including the baby's age in hours, gestational age, relevant neurotoxicity risk factors, and how close the level is to the threshold for phototherapy or other intervention.

Follow-up after discharge also matters. The timing of additional evaluation and bilirubin testing can depend on the predischarge result and the infant's individual risk.

Which Newborns Need Closer Monitoring?

Some infants face a greater risk of developing significant hyperbilirubinemia or bilirubin neurotoxicity.

Relevant factors can include:

• Lower gestational age
• Jaundice appearing during the first 24 hours
• Hemolytic disease, including some blood-group incompatibilities
• G6PD deficiency
• Significant bruising or a scalp hematoma such as a cephalohematoma
• A predischarge bilirubin level close to the phototherapy threshold
• Feeding problems or inadequate intake
• A parent or sibling who previously required phototherapy or exchange transfusion

No single factor proves that kernicterus will develop. These factors help determine which infants may require closer surveillance, testing, or follow-up.

What Happens When Bilirubin Becomes Neurotoxic?

When unconjugated bilirubin reaches sufficiently high levels, it can enter brain tissue and cause bilirubin neurotoxicity.

Early acute bilirubin encephalopathy can include symptoms such as poor feeding, lethargy, altered muscle tone, or difficulty waking. More advanced signs can include a high-pitched cry, marked irritability, abnormal muscle tone, and backward arching of the neck or body.

Prompt treatment at this stage can matter greatly.

Kernicterus describes the permanent neurologic consequences of bilirubin toxicity. Depending on the child, those consequences can include movement disorders such as choreoathetosis or dyskinetic cerebral palsy, sensorineural hearing loss or auditory neuropathy, abnormal upward gaze, and other neurologic impairments.

Once chronic kernicterus develops, the neurologic injury is permanent, although medical treatment, rehabilitation, therapy, and supportive services may help address the child's resulting needs.

Phototherapy, Escalation of Care, and Exchange Transfusion

Treatment decisions for neonatal hyperbilirubinemia are not based on one universal bilirubin number.

AAP treatment thresholds account for the baby's age in hours, gestational age, and recognized neurotoxicity risk factors.

When a bilirubin level reaches the applicable treatment threshold, phototherapy may be indicated. For infants whose levels approach exchange-transfusion thresholds, care may need to escalate quickly, including intensive phototherapy, close bilirubin monitoring, neonatal specialist involvement, and preparation for exchange transfusion when medically indicated.

A malpractice investigation therefore looks at more than whether treatment eventually occurred. Timing can matter.

The records may need to show when bilirubin was measured, what the result was, how that result compared with the applicable treatment threshold, what risk factors clinicians knew about, and how quickly the care plan changed as bilirubin increased.

When Jaundice Care May Warrant a Malpractice Review

Not every case of newborn jaundice, or even every severe bilirubin elevation, means that malpractice occurred.

The legal question is whether the care provided met the applicable standard under the circumstances and whether any departure from that standard caused additional injury.

Depending on the medical history, a review may examine issues such as:

• Whether bilirubin was measured at the appropriate time
• Whether an abnormal result was interpreted using the correct age- and risk-specific threshold
• Whether rising bilirubin levels received appropriate follow-up
• Whether known risk factors were taken into account
• Whether phototherapy was started when clinically indicated
• Whether escalation of care occurred when bilirubin approached dangerous levels
• Whether discharge planning included appropriate bilirubin follow-up
• Whether parents received appropriate instructions about monitoring and returning for care

A clinical guideline can help inform medical review, but a guideline violation does not automatically establish legal negligence. The complete medical record and qualified expert analysis remain central to determining whether the standard of care was breached and whether that breach caused the child's injury.

Discharge and Follow-Up Can Be as Important as In-Hospital Care

Bilirubin can continue to rise after a newborn leaves the hospital.

That makes discharge planning particularly important when a baby's bilirubin level or other risk factors indicate the need for timely reassessment.

A case involving possible premature discharge may require review of the baby's predischarge bilirubin level, age at discharge, gestational age, feeding status, risk factors, follow-up instructions, scheduled appointments, and later bilirubin measurements.

The question is not simply whether the newborn went home early. It is whether the discharge and follow-up plan were appropriate for that particular infant's risk.

Evidence We Review in a Kernicterus Case

Kernicterus claims are heavily dependent on chronology.

A meaningful investigation may require reconstructing exactly what clinicians knew and when they knew it.

Relevant evidence can include:

• Birth and newborn hospital records
• Bilirubin measurements with their date and time
• Gestational age and birth history
• Direct antiglobulin testing and blood-group information when relevant
• Records concerning hemolysis or G6PD deficiency
• Feeding and weight-loss documentation
• Nursing assessments
• Phototherapy records
• Discharge instructions
• Follow-up appointments and telephone communications
• Emergency department or readmission records
• Neurology, audiology, developmental, and rehabilitation records

That timeline can show whether the child's bilirubin was identified and managed appropriately or whether a missed opportunity contributed to bilirubin neurotoxicity.

Our medical malpractice team works with qualified medical professionals to review complex clinical records and evaluate the applicable standard of care and causation.

The Long-Term Impact of Kernicterus

Kernicterus can create lifelong medical and developmental needs.

Depending on the extent of neurologic injury, a child may require audiology care, physical or occupational therapy, mobility assistance, communication support, neurological treatment, educational services, or other forms of long-term care.

Some children affected by kernicterus develop cerebral palsy or other movement disorders. Hearing and auditory-processing injuries are also well-recognized consequences of bilirubin neurotoxicity.

When medical negligence is established, understanding those long-term needs can be important in evaluating damages and the resources a child may require over a lifetime.

Rhode Island Law in a Kernicterus Malpractice Claim

Rhode Island generally requires medical malpractice actions to be filed within three years of the incident giving rise to the claim.

The law contains important provisions for birth injury cases.

If an injured child is a minor and no action is filed within the initial three-year period, Rhode Island law generally allows the child's malpractice action to be brought at any time up to age 21.

Rhode Island also applies a discovery rule when the malpractice injury could not reasonably have been discovered at the time it occurred. In that situation, the statute generally provides three years from when the malpractice should, through reasonable diligence, have been discovered.

Medical malpractice cases also commonly depend on qualified expert testimony. Rhode Island law limits expert testimony regarding alleged malpractice to witnesses qualified by relevant knowledge, skill, experience, training, or education.

The Rhode Island Supreme Court has rejected the older similar-locality standard for physician malpractice. Instead, a physician is measured against the care and skill expected of a reasonably competent practitioner in the same class acting under the same or similar circumstances.

A Rhode Island Medical Malpractice Team With the Resources for Complex Birth Injury Litigation

Decof, Mega & Quinn, P.C. has represented injured clients and families since 1975.

Nine attorneys at the firm have substantial medical malpractice experience, supported by a network of medical consultants and other professionals who can assist with detailed record review and complex medical issues.

Our attorneys have recovered more than $1 billion for clients across the firm's practice. That history includes a $62 million medical malpractice judgment following a $40 million jury verdict in Providence County Superior Court, identified by the firm as Rhode Island's largest medical malpractice verdict.

Our attorneys also bring more than 200 years of combined legal experience.

Past results do not determine what will happen in another case. They do reflect the level of litigation experience and resources available when a birth injury case requires extensive medical investigation and trial preparation.

Decof, Mega & Quinn, P.C. has fought for Rhode Island families in complex medical malpractice cases for nearly five decades. Call us at (401) 200-4059 to speak with one of our birth injury attorneys.